Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027960 (
mole
)
21,279
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have studied the sulfhydryl groups (-SH) on the tryptophanases (TPases) from Escherichia coli B. and E. aurescens, Shigella alkalescens, and Proteus vulgaris and P. morganii. The coli group and the P. morganii apo TPases have 20 -SH groups per
mole
of enzyme, where as P. vulgaris apoTPase has 16. In coli group TPases, there are 16 -SH groups on the
mole
surface and they are all implicated in the activity and the enzyme-substrate bond. Proteus morganii
TPase
has 8 surface -SH groups, 4 of which are implicated in the activity; the remaining 12 -SH groups are located inside the
mole
and take part in the activity and the enzyme-substrate bond. Proteus vulgaris
TPase
has 4 surface -SH groups which are constructive of the enzyme structure, whereas the 12 remaining -SH groups are located inside the
mole
and take part in the activity and the enzyme-substrate bond. It is concluded that Proteus TPases are molecules which have inverted quaternary structure in comparison to those of the coli group. The studied TPases have four subunits, each of them is constituted of one polypeptidic chain having a molecular weight of 55,000.
...
PMID:[Differentiation of tryptophanases of five species of Enterobacteriaceae by sulfhydryl groups]. 109 69
Thymidine phosphorylase/platelet-derived endothelial cell growth factor (
TPase
/PD-ECGF) is a catabolic enzyme that has been shown to be chemotactic for endothelial cells in vitro and angiogenic in vivo.
TPase
/PD-ECGF expression is increased in a variety of tumors. In the skin,
TPase
is active in normal keratinocytes in vitro and in vivo. Our objective was to study the expression and localization of
TPase
/PD-ECGF by immunohistochemical analysis in normal skin and cutaneous tumors and to correlate this information with enzymatic activity of
TPase
.
TPase
/PD-ECGF expression was observed in keratinocytes with intense staining of the infundibulum of hair follicles but no staining of hair bulbs. Expression localized primarily to the nucleus of keratinocytes in the basal layer but was more intense and cytoplasrmic in suprabasal keratinocytes. Increased expression of
TPase
/PD-ECGF in differentiated cells was confirmed by in vitro studies of
TPase
activity. In cutaneous tumors, there was positive staining for
TPase
/ PD-ECGF in squamous cell carcinomas (10/10), eccrine poromas (3/4), eccrine syringomas (4/4), trichoepitheliomas (1/3), and tumors of the follicular infundibulum (2/3) and melanomas (5/8). There was no staining of any intradermal
nevi
(0/2), basal cell carcinomas (0/10) or Merkel cell carcinoma (0/1). We conclude
TPase
/PD-ECGF is found throughout the epidermis and its expression increases with differentiation of keratinocytes. In cutaneous tumors, expression of
TPase
/PD-ECGF may be linked to the cell of origin of the tumor as well as the tumor's degree of differentiation.
...
PMID:Expression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumors. 1047 57